{"store":{"baseInfo":{"podcastTitle":"Cholangio Heroes","slug":"cholangioheroes","podcastDescription":"Cholangio Heroes is a video podcast produced by the Cholangiocarcinoma Foundation that features a wide array of guests impacted by cholangiocarcinoma (bile duct cancer). Raising awareness and education about the complex disease is told through the stories of those it affects the most.","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/14050298/cholangio-heroes-thumb.png","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/14050298/cholangio-heroes-thumb_1200x628.jpg?s=5d40d394d6e1b3abf67afd0c981a5972&e=png","podcastUrl":"https://cholangioheroes.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/cholangioheroes/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pu/pbblog-bvew5-d663fa","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":9,"gmtAdjustment":"GMT-07:00","useDaylightTime":1,"value":-7,"text":"(GMT-07:00) Mountain Time (US & Canada)","daylightStartTime":"Second Sunday Of March +2 Hours","daylightEndTime":"First Sunday Of November +2 Hours","timezone":"America/Denver"},"podcastDownloads":null,"totalEpisodes":34,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"Cholangiocarcinoma Foundation","engagementStatsBaseUrl":null,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-bvew5-d663fa-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Apple Podcasts","link":"https://podcasts.apple.com/us/podcast/cholangio-heroes/id1648001541","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/apple-podcast.png","title":null},{"name":"Podbean App","link":"https://r4j68.app.goo.gl/?link=https%3A%2F%2Fcholangioheroes.podbean.com%3Faction%3DopenPodcast%26podcastId%3Dpbblog14050298%26podcastIdTag%3Dbvew5&dfl=https%3A%2F%2Fcholangioheroes.podbean.com&utm_campaign=pb_web&utm_source=podbean_web&utm_medium=dlink&imv=670&amv=530&isi=973361050&ibi=com.podbean.app.podcast&ipbi=com.podbean.app.podcast&apn=com.podbean.app.podcast","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null},{"name":"Spotify","link":"https://open.spotify.com/show/4DlONTPcuM7HW7alwIfoPR","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/spotify.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Avenir"},{"id":"PlayerColor","val":"#8fc31f"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#7AC142"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"grid"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/6vXEDzczDun3","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-aV68p9FLPHj2","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2022 All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"cholangiocarcinoma","twitter_username":"curecc","instagram_username":"cholangiocarcinoma","youtube_username":"channel/UCBa2G8qD-Fdck5kIuXgQi1w","linkedin_username":""}}],"customize-container1":[],"customize-container2":[{"id":"ComponentImageText-1","val":{"ComponentFontColor":"#000000","ComponentBackgroundColor":"#7AC142","ComponentImage":"https://mcdn.podbean.com/mf/web/ytwhdt/CCF-Vertical.jpg","ComponentContent":"

CHOLANGIOCARCINOMA
Bile Duct Cancer

Cholangiocarcinoma is a rare cancer. Of the top eight deadliest cancers, seven are rare. Rare cancers have a 5-year survival rate under 50% with the cholangiocarcinoma 5-year survival rate being approximately 20%1.

There are three types of cholangiocarcinoma: Intrahepactic, extrahepactic and perihilar, and the mortality rate has increased dramatically in the last decade. According to a recent study, it is estimated that by 2040, liver and bile duct cancer will be the third deadliest cancer in the United States.

More than 10,000 Americans are newly diagnosed with this deadly cancer. Cholangio Heroes is a podcast to raise awareness about the disease and the Cholangiocarcinoma Foundation.

Learn more
at
CHOLANGIOCARCINOMA.ORG

"}}]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":null,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://cholangioheroes.podbean.com","apiCommonParams":{"t":"673ef508","clientSignature":"ca9b5abc0f697450c956d4f20ee650e5","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb19579674-2vk2i","episode":{"id":"pb19579674","idTag":"2vk2i","title":"Cholangio Heroes - Dr. Mark Yarchoan about CCF research funding","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/14050298/cholangio-heroes-thumb_300x300.png","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/14050298/cholangio-heroes-thumb_1200x628.jpg?s=5d40d394d6e1b3abf67afd0c981a5972&e=png","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/14050298/cholangio-heroes-thumb.png","previewContent":null,"content":"

In this episode, Dr. Mark Yarchoan talks about the research funded by the Cholangiocarcinoma Foundation and its advances toward new clinical trials to treat bile duct cancer.
INFO: https://cholangiocarcinoma.org/treatment-options/

","publishTimestamp":1661654412,"duration":1086,"mediaUrl":"https://mcdn.podbean.com/mf/web/jbb4zh/CholangioHeroes_21_-_Mark_Yarchoan81vs8.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-2vk2i-12ac31a","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-2vk2i-12ac31a","transcriptUrl":null,"permalink":"/e/cholangio-heroes-dr-mark-yarchoan/","downloadLink":"https://www.podbean.com/site/EpisodeDownload/PB12AC31A2VK2I","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":25,"status":"publish","hasMoreContent":false,"chaptersUrl":null},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-2vk2i-12ac31a","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false},"episode":{"id":"pb19579674","idTag":"2vk2i","title":"Cholangio Heroes - Dr. Mark Yarchoan about CCF research funding","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/14050298/cholangio-heroes-thumb_300x300.png","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/14050298/cholangio-heroes-thumb_1200x628.jpg?s=5d40d394d6e1b3abf67afd0c981a5972&e=png","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/14050298/cholangio-heroes-thumb.png","previewContent":null,"content":"

Cookies Notice

CHOLANGIOCARCINOMABile Duct Cancer

CHOLANGIOCARCINOMA
Bile Duct Cancer

Cholangio Heroes - Dr. Mark Yarchoan about CCF research funding

Comments (0)